Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Convalescent Plasma for West Nile Fever
NCT06590207Phase 3Completed
- Sponsor
- Sheba Medical Center
- Start
- Jul 2024
- Primary completion
- Jan 2025
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in West Nile fever, sponsored by Sheba Medical Center. Started Jul 2024; status: completed.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
West Nile fever
Beyond the preview
Go deeper on NCT06590207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06590207.